VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
+40.5%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$47M
AUM Growth
-$538M
Cap. Flow
-$548M
Cap. Flow %
-1,166.75%
Top 10 Hldgs %
25.17%
Holding
310
New
6
Increased
35
Reduced
92
Closed
151

Sector Composition

1 Healthcare 88.12%
2 Financials 0.73%
3 Communication Services 0.52%
4 Consumer Discretionary 0.46%
5 Materials 0.36%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EPZM
26
DELISTED
Epizyme, Inc
EPZM
$563K 1.2%
45,462
-5,376
-11% -$66.6K
BIIB icon
27
Biogen
BIIB
$20.3B
$562K 1.2%
2,376
+467
+24% +$110K
SRNE
28
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$512K 1.09%
107,761
-16,062
-13% -$76.3K
ASND icon
29
Ascendis Pharma
ASND
$12.1B
$500K 1.06%
4,250
-539
-11% -$63.4K
VYGR icon
30
Voyager Therapeutics
VYGR
$208M
$491K 1.04%
25,651
-3,556
-12% -$68.1K
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$477K 1.01%
6,506
-778
-11% -$57K
BOLD
32
DELISTED
Audentes Therapeutics, Inc
BOLD
$457K 0.97%
11,716
-1,468
-11% -$57.3K
TGTX icon
33
TG Therapeutics
TGTX
$4.97B
$434K 0.92%
53,943
-7,614
-12% -$61.3K
SAGE
34
DELISTED
Sage Therapeutics
SAGE
$421K 0.9%
2,645
-303
-10% -$48.2K
BLUE
35
DELISTED
bluebird bio
BLUE
$415K 0.88%
203
-24
-11% -$49.1K
EIDX
36
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$413K 0.88%
17,604
-2,072
-11% -$48.6K
CBAY
37
DELISTED
Cymabay Therapeutics
CBAY
$411K 0.87%
30,947
-3,490
-10% -$46.4K
BHVN
38
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$381K 0.81%
7,409
-911
-11% -$46.8K
BPMC
39
DELISTED
Blueprint Medicines
BPMC
$380K 0.81%
4,741
-623
-12% -$49.9K
RETA
40
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$376K 0.8%
4,396
-560
-11% -$47.9K
FGEN icon
41
FibroGen
FGEN
$47.2M
$372K 0.79%
274
-33
-11% -$44.8K
FPRX
42
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$368K 0.78%
27,492
-3,935
-13% -$52.7K
CCXI
43
DELISTED
ChemoCentryx, Inc.
CCXI
$367K 0.78%
26,452
-3,200
-11% -$44.4K
RARX
44
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$363K 0.77%
16,188
-1,662
-9% -$37.3K
OPTN
45
DELISTED
OptiNose
OPTN
$355K 0.76%
2,300
-255
-10% -$39.4K
TCRT icon
46
Alaunos Therapeutics
TCRT
$4.15M
$355K 0.76%
614
-72
-10% -$41.6K
STML
47
DELISTED
Stemline Therapeutics, Inc.
STML
$345K 0.73%
26,854
-2,869
-10% -$36.9K
GBT
48
DELISTED
Global Blood Therapeutics, Inc.
GBT
$336K 0.71%
6,342
-752
-11% -$39.8K
RGNX icon
49
Regenxbio
RGNX
$468M
$335K 0.71%
5,841
-681
-10% -$39.1K
ARWR icon
50
Arrowhead Research
ARWR
$3.85B
$333K 0.71%
18,120
-2,141
-11% -$39.3K